Last reviewed · How we verify
NCT06766227: iEndSmokin
Smoking Cessation App. in Arabic
NA trial testing iEndSmokin App in Smoking Cessation in 150 participants. Not yet recruiting.
1 September 2025
Quick facts
| Lead sponsor | Yarmouk University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 150 |
| Start date | 1 June 2025 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- iEndSmokin App
- Educational Session
Conditions studied
- Smoking Cessation — all drugs for Smoking Cessation →
Sponsor
Yarmouk University
Who can join
18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Smoking remains a significant global health challenge, causing over 8 million deaths annually, with the burden predominantly in low- and middle-income countries. Jordan experiences some of the highest smoking rates worldwide, contributing to substantial health risks and premature mortality. Despite the prevalence of mobile health (mHealth) applications for smoking cessation, few have supported the Arabic language and none have been evaluated for their efficacy. Our main goal is to develop a culture-sensitive mHealth app in Arabic for smoking cessation and test its efficacy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Developing and testing a smoking cessation app in Arabic language: A pilot randomized trial study protocol.
Soudah O, Aldalal'ah M, Alsabbah A, Khasawneh H, et al · · 2025 · PMID 40949668 · DOI 10.1177/20552076251378436
Verify or expand the search:
- PubMed search for NCT06766227
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Smoking Cessation
Currently open trials in the same condition.
- NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
- NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
- NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
- NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
Other Yarmouk University trials
Trials by the same sponsor.
- NCT07294599 — Morning Versus Evening Patching in Childhood Amblyopia · NA · not yet recruiting
- NCT04650035 — The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak · completed
- NCT05106803 — Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan · completed
- NCT06289816 — Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06766227 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yarmouk University
- Last refreshed: 9 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06766227.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing